The EUCROF Podcast: Clinical Research in Europe: The CRO Perspective
Europe has scientific excellence, experienced research networks and diverse patient populations—but as global competition for clinical trials intensifies, can Europe move fast enough to turn its complexity into a competitive advantage?
What needs to change—and what role can CROs play in making it happen?

Latest episodes

Episode 2: From Feasibility to First Patient In - The Reality of Running Clinical Trials Across Europe
A promising therapy, a well-designed protocol, experienced investigators. So why does getting a clinical trial started in Europe remain so challenging? Europe offers world-class clinical research expertise, established research networks and diverse patient populations. Yet the journey from feasibility to first patient in is rarely straightforward. Country-specific requirements, site readiness, recruitment challenges and operational delays can all affect timelines and study success. In the second episode of Clinical Research in Europe: The CRO Perspective, Dr. Krebs-Drouot, Investigator and Medical Lead at Eurofins Optimed, speaks with Ana Maria Iancu from Arensia about what it really takes to get clinical trials up and running across Europe. Drawing on their experience in early-phase clinical development and trial execution, they explore the difference between feasibility on paper and reality at the site, the challenges of patient recruitment, and how earlier collaboration between sponsors, CROs and investigators can help prevent avoidable delays. What stands between a promising clinical trial protocol and the first patient enrolled, and what can Europe’s clinical research community do to close that gap?
They explore the evolving role of CROs, the barriers and opportunities created by Europe’s diverse research environment, and why stronger collaboration and a collective CRO voice could be critical to Europe’s future competitiveness.

Episode 1: Europe as a Global Clinical Research Hub - How CROs Can Help Europe Overcome Complexity and Strengthen Its Global Competitiveness in Clinical Research
In the first episode of Clinical Research in Europe: The CRO Perspective, Doris Neuhauser, EUCROF Executive Board Member and Country Manager at PSI CRO Austria, speaks with Yoanni Matsakis, President of EUCROF and AFCROs and CEO of Telemedicine Technologies, about Europe’s position in global clinical research and clinical development.
They explore the evolving role of CROs, the barriers and opportunities created by Europe’s diverse research environment, and why stronger collaboration and a collective CRO voice could be critical to Europe’s future competitiveness.
New episodes are on their way
Follow the series on Spotify so you never miss a new episode.Meet the speakers
Doris Neuhauser
EUCROF Executive Board Member and Country Manager, PSI CRO Austria
Austria
Yoanni Matsakis
President of EUCROF and AFCROs, CEO of Telemedicine Technologies
France
Lila Krebs-Drouot
Medical Director
France
Ana Maria Iancu
Chair of Early phase Working Group
France